This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jiangsu Province Institute of Traditional Chinese Medicine. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Xue Du
Introduction
Xue Du is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. Her work is characterized by a focus on low toxicity and high safety, which are crucial in the pharmaceutical industry.
Latest Patents
Xue Du holds a patent for a compound of Formula I or its pharmaceutically acceptable salt, along with its preparation method and applications. This compound, which has not been reported in the literature, is isolated from a specific source and serves as a Trx1 selective inhibitor. The invention also includes a pharmaceutical composition and outlines the preparation of the compound, emphasizing its applications in creating medicines for preventing or treating cancer. The compound, referred to as Iso A, boasts advantages such as low toxicity, high safety, and strong pharmacological effects, indicating a promising future in pharmaceutical applications.
Career Highlights
Xue Du is affiliated with the Jiangsu Province Institute of Traditional Chinese Medicine, where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the field of medicinal chemistry.
Collaborations
Xue Du collaborates with notable colleagues, including Peng Cao and Jianxin Pu, who contribute to her research endeavors and enhance the impact of her work.
Conclusion
Xue Du's contributions to the field of pharmaceuticals, particularly through her innovative patent, highlight her role as a leading inventor in cancer treatment research. Her focus on safety and efficacy in drug development underscores the importance of her work in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile